Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 2

Results: 20

Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 437, doi. 10.1007/s00262-022-03259-5

By:

Yuan, Shumin;
Peng, Ling;
Liu, Yuqing;
Till, Brian G.;
Yan, Xiang;
Zhang, Jie;
Zhu, Liping;
Wang, Huijuan;
Zhang, Shaokai;
Li, Hongle;
Gao, Quanli;
Wang, Zibing

Publication type:

Article

CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 277, doi. 10.1007/s00262-022-03260-y

By:

Ganapathy, Thamizhselvi;
Radhakrishnan, Rajalingam;
Sakshi, Seth;
Martin, Sunil

Publication type:

Article

Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 515, doi. 10.1007/s00262-022-03264-8

By:

Ballhausen, Alexej;
Ben Hamza, Amin;
Welters, Carlotta;
Dietze, Kerstin;
Bullinger, Lars;
Rahn, Hans-Peter;
Hartmann, Sylvia;
Hansmann, Martin-Leo;
Hansmann, Leo

Publication type:

Article

Single-cell analysis of peripheral CD8<sup>+</sup> T cell responses in patients receiving checkpoint blockade immunotherapy for cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 397, doi. 10.1007/s00262-022-03263-9

By:

Khojandi, Niloufar;
Connelly, Louis;
Piening, Alexander;
Hoft, Stella G.;
Pherson, Michelle;
Donlin, Maureen J.;
DiPaolo, Richard J.;
Teague, Ryan M.

Publication type:

Article

A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 351, doi. 10.1007/s00262-022-03255-9

By:

Kuo, Cheng-Liang;
Chou, Han-Yu;
Lien, Hui-Wen;
Yeh, Chia-An;
Wang, Jing-Rong;
Chen, Chung-Hsing;
Fan, Chi-Chen;
Hsu, Chih-Ping;
Kao, Ting-Yu;
Ko, Tai-Ming;
Lee, Alan Yueh-Luen

Publication type:

Article

Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 493, doi. 10.1007/s00262-022-03267-5

By:

Wang, Jie;
Li, Chen;
He, Kaijie;
Kuang, Zhihui;
Lu, Jia;
Yao, Ying;
He, Fufan;
Li, Ninghuan;
Li, Li;
Fu, Fenggen;
Wu, Zhihai;
Zhou, Shuaixiang;
Kang, Dian;
Qiu, Xuan;
Wu, Min;
Liu, Yang;
Cao, Xiaochao;
Xu, Mengqiu;
Chen, Bingliang;
Wu, Weiwei

Publication type:

Article

Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 461, doi. 10.1007/s00262-022-03266-6

By:

Lauridsen, Kasper Munch;
Hokland, Marianne;
Al-Karradi, Sinan;
Møller, Holger Jon;
Donskov, Frede;
Andersen, Morten Nørgaard

Publication type:

Article

Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 427, doi. 10.1007/s00262-022-03265-7

By:

Ikoma, Tatsuki;
Shimokawa, Mototsugu;
Matsumoto, Toshihiko;
Boku, Shogen;
Yasuda, Tomoyo;
Shibata, Nobuhiro;
Kurioka, Yusuke;
Takatani, Masahiro;
Nobuhisa, Tetsuji;
Namikawa, Tsutomu;
Kitagawa, Hiroyuki;
Hanazaki, Kazuhiro;
Doi, Keitaro;
Shimada, Takanobu;
Tsumura, Takehiko;
Marusawa, Hiroyuki;
Kanaya, Seichiro;
Morita, Shuko;
Inokuma, Tetsurou;
Nagai, Hiroki

Publication type:

Article

Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 371, doi. 10.1007/s00262-022-03258-6

By:

Jeon, Seung Hyuck;
Lee, Yong Joon;
Kim, Hyung-Don;
Nam, Heejin;
Ryoo, Baek-Yeol;
Park, Su-Hyung;
Yoo, Changhoon;
Shin, Eui-Cheol

Publication type:

Article

High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in advanced colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 315, doi. 10.1007/s00262-022-03256-8

By:

Hexun, Zhang;
Miyake, Toru;
Maekawa, Takeru;
Mori, Haruki;
Yasukawa, Daiki;
Ohno, Masashi;
Nishida, Atsushi;
Andoh, Akira;
Tani, Masaji

Publication type:

Article

Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 523, doi. 10.1007/s00262-022-03261-x

By:

Sasatani, Yuika;
Ojima, Eiji;
Satoh, Hiroaki

Publication type:

Article

Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 287, doi. 10.1007/s00262-022-03245-x

By:

Cho, Helen;
Binder, Joe;
Weeratna, Risini;
Dermyer, Michael;
Dai, Stanley;
Boccia, Antionio;
Li, Wei;
Li, Shangjin;
Jooss, Karin;
Merson, James;
Hollingsworth, Robert E.

Publication type:

Article

Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 327, doi. 10.1007/s00262-022-03241-1

By:

Yan, Haimeng;
He, Donghua;
Qu, Jianwei;
Liu, Yang;
Xu, Ruyi;
Gu, Huiyao;
Chen, Jing;
Li, Yi;
Zhang, Enfan;
Zhao, Yi;
He, Jingsong;
Cai, Zhen

Publication type:

Article

Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 409, doi. 10.1007/s00262-022-03238-w

By:

Chen, Jiannan;
Hu, Jianhua;
Gu, Lili;
Ji, Feng;
Zhang, Fan;
Zhang, Miaomiao;
Li, Jun;
Chen, Zhengliang;
Jiang, Longwei;
Zhang, Yan;
Shi, Ruifang;
Ma, Lihua;
Jia, Shaochang;
Zhang, Ying;
Zhang, Qi;
Liang, Junqing;
Yao, Shunyu;
Hu, Zhigang;
Guo, Zhigang

Publication type:

Article

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 475, doi. 10.1007/s00262-022-03253-x

By:

De Jaeghere, Emiel A.;
Tuyaerts, Sandra;
Van Nuffel, An M. T.;
Belmans, Ann;
Bogaerts, Kris;
Baiden-Amissah, Regina;
Lippens, Lien;
Vuylsteke, Peter;
Henry, Stéphanie;
Trinh, Xuan Bich;
van Dam, Peter A.;
Aspeslagh, Sandrine;
De Caluwé, Alex;
Naert, Eline;
Lambrechts, Diether;
Hendrix, An;
De Wever, Olivier;
Van de Vijver, Koen K.;
Amant, Frédéric;
Vandecasteele, Katrien

Publication type:

Article

Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 385, doi. 10.1007/s00262-022-03254-w

By:

An, Mengchao;
Wang, Wenkang;
Zhang, Jie;
Till, Brian G.;
Zhao, Lingdi;
Huang, Hao;
Yang, Yonghao;
Li, Tiepeng;
Han, Lu;
Zhang, Xiaojie;
Qin, Peng;
Wang, Yunjian;
Zhang, Min;
Cui, Hong;
Gao, Quanli;
Wang, Zibing

Publication type:

Article

Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 339, doi. 10.1007/s00262-022-03252-y

By:

Gao, Yinjie;
Stein, Michelle M.;
Kase, Matthew;
Cummings, Amy L.;
Bharanikumar, Ramit;
Lau, Denise;
Garon, Edward B.;
Patel, Sandip P.

Publication type:

Article

Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 449, doi. 10.1007/s00262-022-03251-z

By:

Feng, Yu;
Tang, Le;
Wang, Hongyu;
Liu, Yutao;
Yang, Sheng;
Lin, Lin;
Hu, Xingsheng;
Shi, Yuankai

Publication type:

Article

Personalized tumor vaccine for pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 301, doi. 10.1007/s00262-022-03237-x

By:

Orr, Shira;
Huang, Ling;
Moser, James;
Stroopinsky, Dina;
Gandarilla, Omar;
DeCicco, Cori;
Liegel, Jessica;
Tacettin, Cansu;
Ephraim, Adam;
Cheloni, Giulia;
Torres, Daniela;
Kufe, Donald;
Rosenblatt, Jacalyn;
Hidalgo, Manuel;
Muthuswamy, Senthil K.;
Avigan, David

Publication type:

Article

Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma.

Published in:

2023

By:

Zhang, Xin-Wen;
Wald, Alexander;
Salzmann, Martin;
Halama, Niels;
Hassel, Jessica C.

Publication type:

Case Study